Drug & intervention

taletrectinib

RxCUI 2716919

Clinical trials7

Recruiting3

Related conditions17

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

7 shown

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)NCT07154706 · 2025-08-21

Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain MetastasesNCT07008287 · 2025-06-04

A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer PatientsNCT06564324 · 2024-11-27

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)NCT06214793 · 2026-10-01

Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib ProgressionNCT07199010 · 2025-10-01

NOT_YET_RECRUITING

Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLCNCT04919811 · 2021-09-01

ACTIVE_NOT_RECRUITING

Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNCT06841874

NO_LONGER_AVAILABLE

Conditions being studied

Non Small Cell Lung Cancer2 Breast Cancer1 Bronchogenic Carcinoma1 Carcinoma1 Lung Diseases1 Lung Neoplasms1 Metastatic Breast Cancer1 Neoplasms1 Neoplasms by Site1 Non Small Cell Carcinoma of the Lung1 Non-Small Cell Lung Cancer1 Non-small Cell Lung Cancer (NSCLC)1 Non-small Lung Cancer1 Respiratory Tract Diseases1 Respiratory Tract Neoplasms1 ROS1-positive Non-Small Cell Lung Cancer (NSCLC)1 Thoracic Neoplasms1

Research locations

ShanghaiShanghai Municipality, China4 BeijingBeijing Municipality, China3 HangzhouZhejiang, China3 ZhengzhouHenan, China3 ChengduSichuan, China2 ClevelandOhio, United States2 GuangzhouGuangdong, China2 HoustonTexas, United States2 Los AngelesCalifornia, United States2 MontrealQuebec, Canada2 NanchangJiangxi, China2 NanjingJiangsu, China2

Leading sponsors

Nuvation Bio Inc.4 Innovent Biologics (Suzhou) Co. Ltd.2 Megan Kruse, MD1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.